BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukemia
,
Heart
,
Neocentromeres
,
Vitamin E
,
rs3825942
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SR- A1
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
HCT116 Dicer hypomorphs transfected with miRNAs from miR-16 family
Explore Curated Studies Results
Literature
Most Relevant Literature
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.
Analysis of the acrolein-modified sites of apolipoprotein B-100 in LDL.
Phenotypic screens identify SCAF1 as critical activator of RNAPII elongation and global transcriptio…
Detailed role of SR-A1 and SR-E3 in tumor biology, progression, and therapy.
Optic atrophy 1 mediates muscle differentiation by promoting a metabolic switch via the supercomplex…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Percutaneous Release vs Steroid Injection for Trigger Finger
Clinical Study of Artz in the Treatment of Knee Osteoarthritis
Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma
Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphob…
Terazosin and Parkinson's Disease Extension Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ